Results 11 to 20 of about 517 (142)

Synthesis and cytotoxicity evaluation of fluorinated brusatol, bruceosin, and dehydrobrusatol

open access: yesResults in Chemistry, 2023
Three fluorinated quassinoid analogues—4α-fluorobruceosin, 1α-fluorobrusatol, and 1-fluorodehydrobrusatol—were synthesized from brusatol, bruceosin, and dehydrobrusatol, respectively, by treatment with Selectfluor.
Yukio Hitotsuyanagi   +5 more
doaj   +3 more sources

Brusatol, an NRF2 inhibitor for future cancer therapeutic [PDF]

open access: yesCell & Bioscience, 2019
Background Natural products from herbal medicines have long been investigated for their potentials as cancer therapeutics. Besides the development of several herbal medicine-derived anti-cancer agents, such as paclitaxel, vincristine and podophyllotoxin,
Sabrina J. Cai   +3 more
doaj   +3 more sources

Brusatol [PDF]

open access: yesActa Crystallographica Section E, 2012
The title compound, C26H32O11, is composed of an α,β-unsaturated cyclohexanone ring (A), two cyclohexane rings (B and C), a six-membered lactone ring (D) and tetrahydrofuran ring (E).
Shu-Zhi Hu   +4 more
doaj   +3 more sources

Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism [PDF]

open access: yesProceedings of the National Academy of Sciences, 2011
The major obstacle in cancer treatment is the resistance of cancer cells to therapies. Nrf2 is a transcription factor that regulates a cellular defense response and is ubiquitously expressed at low basal levels in normal tissues due to Keap1-dependent ubiquitination and proteasomal degradation.
Dongmei, Ren   +6 more
openaire   +3 more sources

Repositioning Brusatol as a Transmission Blocker of Malaria Parasites [PDF]

open access: yesACS Infectious Diseases
Currently, primaquine is the only malaria transmission-blocking drug recommended by the WHO. Recent efforts have highlighted the importance of discovering new agents that regulate malarial transmission, with particular interest in agents that can be administered in a single low dose, ideally with a discrete and Plasmodium-selective mechanism of action.
Amelia Cox   +6 more
openaire   +5 more sources

Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol

open access: yesFrontiers in Pharmacology
Ethnopharmacological RelevanceQuassinoid brusatol, isolated from the traditional Chinese medicine Brucea javanica (L.) Merr., significantly increases the intracellular concentration of cisplatin and reduces tumor size by inhibiting the Nrf2 pathway ...
Nan Guo   +5 more
doaj   +3 more sources

Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats

open access: yesRedox Report, 2023
Objectives To observe the protective effects of dexmedetomidine (Dex) postconditioning on myocardial ischemia/reperfusion injury (IRI) and to explore its potential molecular mechanisms.Methods One-hundred forty-seven male Sprague-Dawley rats were ...
Bin Hu   +9 more
doaj   +2 more sources

Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy [PDF]

open access: yesAntioxidants, 2022
Acute myeloid leukemia (AML) is a molecularly heterogenous hematological malignancy, with one of the most common mutations being internal tandem duplication (ITD) of the juxtamembrane domain of the fms-like tyrosine kinase receptor-3 (FLT3).
Sankaranarayan Kannan   +10 more
doaj   +2 more sources

Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer

open access: yesPharmaceutics
Challenges to docetaxel use in prostate cancer treatment include several resistance mechanisms as well as toxicity. To overcome these challenges and to improve the therapeutic efficacy in heterogeneous prostate cancer, the use of multiple agents that can
Tayo Alex Adekiya   +5 more
doaj   +2 more sources

Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma

open access: yesBiomolecules, 2019
STAT3 is a latent transcription factor that plays a vital role in the transmission of extracellular signal from receptors to the nucleus. It has been regarded as a master transcription factor due to its role in the regulation of a broad spectrum of genes,
Jong Hyun Lee   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy